Metabolic impact of switching from EFV/TDF/FTC to two INSTI-Based regimens (B/F/TAF vs. DTG/3TC): a real-world study in virologically suppressed individuals
Frontiers in Pharmacology · 31.03.2026 · 17
DOI: 10.3389/fphar.2026.1753242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 31.03.2026. Verfasst von Er Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To compare metabolic outcomes in virologically suppressed PLWH switching from EFV/TDF/3TC to either B/F/TAF or DTG/3TC.
Methods
In this retrospective real-world study of 326 patients, weight, lipid (TG, TC), glucose (GLU), and uric acid (SUA) changes were assessed over 24 months. Generalized linear mixed models and logistic regression identified factors associated with metabolic trends and clinically significant weight gain (>5%).
Results
The B/F/TAF and DTG/3TC groups showed no significant between-group differences in the longitudinal trends of TG, TC, GLU, or SUA, the incidence of metabolic abnormalities, or the risk of >5% weight gain (all P > 0.05). Within-group analyses indicated the B/F/TAF regimen increased TC ( P < 0.001) and decreased GLU ( P = 0.013), whereas DTG/3TC did not significantly alter TG, TC, or GLU levels. Both regimens increased SUA and body weight (B/F/TAF: +2.5 kg; DTG/3TC: +3.3 kg; both P < 0.001). Modifiable risk factors were associated with metabolic outcomes: smoking with increased TG and TC; hypertension and BMI≥25 kg/m 2 with increased TC, GLU, and SUA; age≥50 years with increased GLU and SUA; and regular alcohol consumption with >5% weight gain (adjusted OR = 1.92, P = 0.008). These findings remained consistent in participants with hypertension.
Conclusion
In virologically suppressed PLWH, switching to B/F/TAF or DTG/3TC provides comparable metabolic safety profiles. Clinical management should prioritize individualized regimen selection alongside proactive management of traditional metabolic risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affiliated Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
- Xihu District Center for Disease Control and Prevention, Hangzhou, China.
Zitieren
APA
Li, E., Wang, Y., Yan, D., Shi, J., Yu, J., Hu, X., & Zhang, W. (2026). Metabolic impact of switching from EFV/TDF/FTC to two INSTI-Based regimens (B/F/TAF vs. DTG/3TC): a real-world study in virologically suppressed individuals. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1753242
Vancouver
Li E, Wang Y, Yan D, Shi J, Yu J, Hu X, et al. Metabolic impact of switching from EFV/TDF/FTC to two INSTI-Based regimens (B/F/TAF vs. DTG/3TC): a real-world study in virologically suppressed individuals. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1753242
BibTeX
@article{Li2026,
author = {Li, Er and Wang, Yi and Yan, Dingyan and Shi, Jinchuan and Yu, Jianhua and Hu, Xiaowei and Zhang, Wenhui},
title = {Metabolic impact of switching from EFV/TDF/FTC to two INSTI-Based regimens (B/F/TAF vs. DTG/3TC): a real-world study in virologically suppressed individuals},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1753242}
}
EUVIMED